Accessing Cell and Gene Therapies: Insights on Coverage, Reimbursement and Emerging Models | Manatt, Phelps & Phillips, LLP

Editor’s Note: In a new white paper, summarized below, Manatt Health discusses emerging reimbursement models for cell and gene therapies. The paper provides an overview of current...

Related Keywords

United States ,American ,Americans ,Phelps Phillips ,Scott Gottlieb ,Peter Marks ,Medicaid Budget Survey For State Fiscal Years ,Manatt Health ,Program Administration ,American Society Of Gene ,Medicare Program ,Medicaid Drug Rebate Program ,Centers For Medicare Medicaid Services ,Drug Administration ,Medicaid Program ,National Drug Rebate Agreement ,Gene Therapy ,Medicaid Services ,Gene Therapy Access Model ,New Technology Add On Payments ,Prospective Payment System ,Medicaid Innovation ,Magellan Rx Medical Pharmacy Report ,Biologics Evaluation ,Executive Order ,Lowering Prescription Drug Costs ,Cell Therapy ,Social Security Act ,Program Integrity Updates Under ,Medicaid Drug Rebate ,Hospital Inpatient Prospective Payment Systems ,Acute Care Hospitals ,Policy Changes ,Fiscal Year ,Equality Programs ,Eligible Hospitals ,Critical Access Hospitals ,Costs Incurred ,Non Qualified Deferred Compensation Plans ,Critical Access Hospital Conditions ,Pandemic Continues ,Shape Medicaid Priorities ,Annual Medicaid Budget Survey ,State Fiscal Years ,